ConductScience.org, home

Paper33816577

Stepwise Reversion of Multiply Mutated Recombinant Antitrypsin Reveals a Selective Inhibitor of Coagulation Factor XIa as Active as the M358R Variant.

Hamada M and 3 others. Front Cardiovasc Med, 2021. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Stepwise Reversion of Multiply Mutated Recombinant Antitrypsin Reveals a Selective Inhibitor of Coagulation Factor XIa as Active as the M358R Variant. Papers, record 33816577. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33816577

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Stepwise Reversion of Multiply Mutated Recombinant Antitrypsin Reveals a Selective Inhibitor of Coagulation Factor XIa as Active as the M358R Variant.
PubMed
Journal
Front Cardiovasc Med
PubMed
Year
2021
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
0.44
iCite
Revised in PubMed
2021-04-06
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hamada MMostafa
2Bhakta VVarsha
3Andres SNSara N
4Sheffield WPWilliam P

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References53

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133692375Identification of an alpha-1 antitrypsin variant with enhanced specificity for factor XIa by phage display, bacterial expression, and combinatorial mutagenesis.Sci Rep2021https://conductscience.org/library/papers/33692375PubMed
215829482Exosite-mediated substrate recognition of factor IX by factor XIa. The factor XIa heavy chain is required for initial recognition of factor IX.J Biol Chem2005https://conductscience.org/library/papers/15829482PubMed
323996272How good is automated protein docking?Proteins2013https://conductscience.org/library/papers/23996272PubMed
416176258Control of the coagulation system by serpins. Getting by with a little help from glycosaminoglycans.FEBS J2005https://conductscience.org/library/papers/16176258PubMed
521778227The role of factor XIa (FXIa) catalytic domain exosite residues in substrate catalysis and inhibition by the Kunitz protease inhibitor domain of protease nexin 2.J Biol Chem2011https://conductscience.org/library/papers/21778227PubMed
627789479Design and characterization of an APC-specific serpin for the treatment of hemophilia.Blood2017https://conductscience.org/library/papers/27789479PubMed
78439290Evolutionary families of peptidases.Biochem J1993https://conductscience.org/library/papers/8439290PubMed
87592834Coagulation factor XIa cleaves the RHDS sequence and abolishes the cell adhesive properties of the amyloid beta-protein.J Biol Chem1995https://conductscience.org/library/papers/7592834PubMed
916321984Active site distortion is sufficient for proteinase inhibition by serpins: structure of the covalent complex of alpha1-proteinase inhibitor with porcine pancreatic elastase.J Biol Chem2006https://conductscience.org/library/papers/16321984PubMed
1021057700Patients with severe factor XI deficiency have a reduced incidence of deep-vein thrombosis.Thromb Haemost2011https://conductscience.org/library/papers/21057700PubMed
1119617576Coagulation factors IX through XIII and the risk of future venous thrombosis: the Longitudinal Investigation of Thromboembolism Etiology.Blood2009https://conductscience.org/library/papers/19617576PubMed
1227936493New additions to the ClusPro server motivated by CAPRI.Proteins2017https://conductscience.org/library/papers/27936493PubMed
1316085935Structural and mutational analyses of the molecular interactions between the catalytic domain of factor XIa and the Kunitz protease inhibitor domain of protease nexin 2.J Biol Chem2005https://conductscience.org/library/papers/16085935PubMed
1431366623Design and characterization of α1-antitrypsin variants for treatment of contact system-driven thromboinflammation.Blood2019https://conductscience.org/library/papers/31366623PubMed
1516931632Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: Opposite and synergistic effects of factors XI and XII.Blood2006https://conductscience.org/library/papers/16931632PubMed
1624977287Antigen levels of coagulation factor XII, coagulation factor XI and prekallikrein, and the risk of myocardial infarction and ischemic stroke in young women.J Thromb Haemost2014https://conductscience.org/library/papers/24977287PubMed
1721781239Serpin structure, function and dysfunction.J Thromb Haemost2011https://conductscience.org/library/papers/21781239PubMed
181888745Mechanism of serpin action: evidence that C1 inhibitor functions as a suicide substrate.Biochemistry1991https://conductscience.org/library/papers/1888745PubMed
197534133Inactivation of factor XIa in human plasma assessed by measuring factor XIa-protease inhibitor complexes: major role for C1-inhibitor.Blood1995https://conductscience.org/library/papers/7534133PubMed
2032268028Alpha1-Antitrypsin Deficiency.N Engl J Med2020https://conductscience.org/library/papers/32268028PubMed

See all 53 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
40607491Expression and purification of a broad-spectrum human protease inhibitor in Pichia pastoris.Biochem Biophys Rep2025https://conductscience.org/library/papers/40607491PubMed
40075385Enhancement of plasma kallikrein specificity of antitrypsin variants identified by phage display and partial reversion.BMC Biotechnol2025https://conductscience.org/library/papers/40075385PubMed
39441778Prolonging the circulatory half-life of C1 esterase inhibitor via albumin fusion.PLoS One2024https://conductscience.org/library/papers/39441778PubMed
37158379The under-appreciated world of the serpin family of serine proteinase inhibitors.EMBO Mol Med2023https://conductscience.org/library/papers/37158379PubMed

Download CSV of cited by

Genes14

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33816577

GET https://conductscience.org/api/papers/v1/33816577/references?page=2